TIM3+ cells in gastric cancer: clinical correlates and association with immune context
K Chen, Y Gu, Y Cao, H Fang, K Lv, X Liu, X He… - British Journal of …, 2022 - nature.com
Background T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) is a
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
TIM3+ cells in gastric cancer: clinical correlates and association with immune context.
K Chen, Y Gu, Y Cao, H Fang, K Lv, X Liu… - British Journal of …, 2021 - europepmc.org
Background T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) is a
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
TIM3+ cells in gastric cancer: clinical correlates and association with immune context
K Chen, Y Gu, Y Cao, H Fang, K Lv… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) is a
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
[HTML][HTML] TIM3+ cells in gastric cancer: clinical correlates and association with immune context
K Chen, Y Gu, Y Cao, H Fang, K Lv, X Liu… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Background T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) is a
crucial immune checkpoint and is considered as an emerging target for cancer treatment …
crucial immune checkpoint and is considered as an emerging target for cancer treatment …